Topline data from Phase 2b/3 trial of izokibep as a treatment for non-infectious non-anterior uveitis expected in December 2024 Positive lonigutamab EOP2 FDA interaction completed and initiation of ...

H.C. Wainwright raised the firm’s price target on Viridian Therapeutics (VRDN) to $34 from $27 and keeps a Buy rating on the shares. The ...

Ocular autoimmune disease involves the immune system attacking the tissues of the eye. These diseases typically manifest through an autoantibody response targeting the retina, uvea, vitreous, and ...

Selenium supplementation has also been examined for the treatment of mild, active TED. Selenium is a trace mineral and an essential nutrient for selenocysteine synthesis, which has antioxidant ...

“Are the medications the cause or are they potentially an aggravating factor on a baseline issue?” said Snyder. A new study ...

As the battle against obesity and diabetes heats up, two new superstars are entering the ring in Spain - Mounjaro (also known ...

Analysts have set 12-month price targets for Amgen, revealing an average target of $349.0, a high estimate of $405.00, and a ...

I had never seen this bird's-eye angle: It was clear my temples were receding, too, revealing parabola-shaped patches of ...

Illustrating the Progression of Thyroid Eye Disease Thyroid Eye Disease often ... TikTok's Fave Weight Loss Drugs: Link to Thyroid Cancer? Demand for Ozempic continues to surge, fueled by social ...

A doctor who was watching Nicole McGuiness on Beachfront Bargain Hunt contacted the house hunter after seeing an abnormal ...

Assetmark Inc. boosted its stake in shares of Genmab A/S (NASDAQ:GMAB – Free Report) by 16.2% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 82,629 shares of ...